Skip to main content
. Author manuscript; available in PMC: 2020 May 13.
Published in final edited form as: Cancer Gene Ther. 2009 Oct 9;17(3):155–163. doi: 10.1038/cgt.2009.63

Figure 7.

Figure 7

Increased cytotoxicity of bax mutant in various tumor cell lines. Human breast cancer cell lines SKBR3 (a) MDA MB231 (b) and MCF7 (c) human colon cancer cell line HT29 (d) mouse breast cancer cell lines DA-3 (e) or mouse neuroblastoma cell line TBJ (f) were co-transfected with various bax constructs with a luciferase reporter plasmid as in previous experiments. Relative survival was determined 48 h later as percent luciferase activity of control-transfected cells. Data are mean ± s.d. of three independent observations (*P<0.001).